Beyfortus 50 mg/0.5 ml
Beyfortus 50 mg/0.5 ml is a medicine authorised by Swissmedic under authorisation number 69039. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 22 December 2023 and the authorisation is limited until 21 December 2028. ATC code J06BD08 places the medicine in the group Immune sera and immunoglobulins.
| Authorisation number | 69039 |
|---|---|
| Name | Beyfortus 50 mg/0.5 ml |
| Full name | Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J06BD08 |
| First authorisation | 22 December 2023 |
| Authorisation validity | 21 December 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie | A | 22 December 2023 |
| 2 | Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie | A | 22 December 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | J06BD08 | 08.03.0. | A |
| 2 | 1 | Fertigspritze(n) | J06BD08 | 08.03.0. | A |
| 3 | 1 | Fertigspritze(n) | J06BD08 | 08.03.0. | A |
| 4 | 1 | Fertigspritze(n) | J06BD08 | 08.03.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Beyfortus 50 mg/0.5 ml authorised in Switzerland?
Yes. Beyfortus 50 mg/0.5 ml is authorised by Swissmedic under authorisation number 69039, data as of 01 September 2026. The authorisation is limited until 21 December 2028.
Which dispensing category does Beyfortus 50 mg/0.5 ml have?
Beyfortus 50 mg/0.5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Beyfortus 50 mg/0.5 ml?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.